Akums Drugs and Pharmaceuticals Limited
NSE: AKUMS | Information Technology
Market Fundamentals
Stock Intelligence & News
Akums Drugs and Pharmaceuticals Limited
Akums Drugs and Pharmaceuticals Limited has informed the Exchange about Schedule of meet |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
Read Full Analysis →Akums Drugs and Pharmaceuticals Ltd (544222)
Intimation of Schedule of the Investors/Analysts Meet
Read Full Analysis →Akums Drugs and Pharmaceuticals Ltd (544222)
Transcript of Investors/Analysts conference call for the unaudited financial results of Q1 FY 27
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Akums Drugs and Pharmaceuticals Limited
Akums Drugs and Pharmaceuticals Limited has informed the Exchange about Transcript |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
Read Full Analysis →Akums Drugs, CDSL, Ceigall India, Power Mech In Focus After Q1; ICICI Securities Sees Up To 22% Upside — Check Ratings
Stocks To Watch: Akums Drugs, CDSL, Ceigall India, Power Mech; ICICI Securities Sees Up To 22% Upside
Read Full Analysis →Akums Drugs and Pharmaceuticals Limited
Copy of Newspaper Publication |SUBJECT: Copy of Newspaper Publication
Read Full Analysis →Akums Drugs and Pharmaceuticals Ltd (544222)
Newspaper Publication
Read Full Analysis →Akums Drugs and Pharmaceuticals Limited
Monitoring Agency Report for the quarter ended June 30, 2026 |SUBJECT: Monitoring Agency Report
Read Full Analysis →Akums Drugs and Pharmaceuticals Ltd (544222)
Monitoring Agency Report for the quarter ended June 30, 2026
Read Full Analysis →Akums Drugs shares rally 9% hit 52-week high after Q1 results; stock up 67% YTD
Akums Drugs shares rose sharply on Monday to hit a 52-week high after the company reported strong Q1 FY27 results. Revenue rose 13.9% year-on-year, while profit increased 55%. EBITDA grew 35.4%, supported by strong performance in its CDMO business. The stock has gained 67% so far this year.
Read Full Analysis →Get instant alerts when AKUMS breaks news
Join investors who track Akums Drugs and Pharmaceuticals Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for AKUMS?
AKUMS is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Akums Drugs and Pharmaceuticals Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding AKUMS to your custom watchlist.